ATE457160T1 - Vanillin-polymere zwecks verwendung zur verdunklung der haut - Google Patents

Vanillin-polymere zwecks verwendung zur verdunklung der haut

Info

Publication number
ATE457160T1
ATE457160T1 AT04813962T AT04813962T ATE457160T1 AT E457160 T1 ATE457160 T1 AT E457160T1 AT 04813962 T AT04813962 T AT 04813962T AT 04813962 T AT04813962 T AT 04813962T AT E457160 T1 ATE457160 T1 AT E457160T1
Authority
AT
Austria
Prior art keywords
skin
darken
vanillin
polymers
vanillin polymers
Prior art date
Application number
AT04813962T
Other languages
English (en)
Inventor
Connie Baozhen Lin
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Application granted granted Critical
Publication of ATE457160T1 publication Critical patent/ATE457160T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT04813962T 2003-12-12 2004-12-09 Vanillin-polymere zwecks verwendung zur verdunklung der haut ATE457160T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/735,540 US7935331B2 (en) 2003-12-12 2003-12-12 Vanillin polymers for use in darkening the skin
PCT/US2004/041716 WO2005058262A1 (en) 2003-12-12 2004-12-09 Vanillin polymers for use in darkening the skin

Publications (1)

Publication Number Publication Date
ATE457160T1 true ATE457160T1 (de) 2010-02-15

Family

ID=34653644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04813962T ATE457160T1 (de) 2003-12-12 2004-12-09 Vanillin-polymere zwecks verwendung zur verdunklung der haut

Country Status (6)

Country Link
US (1) US7935331B2 (de)
EP (1) EP1701689B1 (de)
AT (1) ATE457160T1 (de)
CA (1) CA2547762C (de)
DE (1) DE602004025507D1 (de)
WO (1) WO2005058262A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8278359B2 (en) 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
EP2011471A1 (de) * 2007-07-02 2009-01-07 Johnson & Johnson Consumer France SAS Schäumende Ölzubereitungen
EP2172475B1 (de) * 2007-07-05 2015-06-03 Nissan Chemical Industries, Ltd. Lipidpeptid verwendet als hydrogel
US20090087395A1 (en) * 2007-10-01 2009-04-02 Lin Connie B Compositions for use in darkening the skin
US8481006B2 (en) * 2008-04-25 2013-07-09 New Sunshine, Llc Melt formula
IT1394672B1 (it) * 2009-02-11 2012-07-13 Wellpharma S R L Preparazione topica
US8999300B2 (en) * 2009-10-26 2015-04-07 Nissan Chemical Industries Ltd. Cosmetic, external skin preparation, and medical instrument
US9475709B2 (en) 2010-08-25 2016-10-25 Lockheed Martin Corporation Perforated graphene deionization or desalination
BR112013006232A2 (pt) * 2010-09-22 2019-09-24 L´Oreal processo de tratamento cosmético, composto e composição cosmética
KR101769456B1 (ko) 2011-05-26 2017-08-30 주식회사 엘지생활건강 유통기한의 경과에 대한 표시 기능을 가진 화장료 조성물
US10980919B2 (en) 2016-04-14 2021-04-20 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
US10118130B2 (en) 2016-04-14 2018-11-06 Lockheed Martin Corporation Two-dimensional membrane structures having flow passages
US10653824B2 (en) 2012-05-25 2020-05-19 Lockheed Martin Corporation Two-dimensional materials and uses thereof
US10418143B2 (en) 2015-08-05 2019-09-17 Lockheed Martin Corporation Perforatable sheets of graphene-based material
US9744617B2 (en) 2014-01-31 2017-08-29 Lockheed Martin Corporation Methods for perforating multi-layer graphene through ion bombardment
US10376845B2 (en) 2016-04-14 2019-08-13 Lockheed Martin Corporation Membranes with tunable selectivity
US9610546B2 (en) 2014-03-12 2017-04-04 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US10696554B2 (en) 2015-08-06 2020-06-30 Lockheed Martin Corporation Nanoparticle modification and perforation of graphene
US9834809B2 (en) 2014-02-28 2017-12-05 Lockheed Martin Corporation Syringe for obtaining nano-sized materials for selective assays and related methods of use
US9592475B2 (en) 2013-03-12 2017-03-14 Lockheed Martin Corporation Method for forming perforated graphene with uniform aperture size
US9572918B2 (en) 2013-06-21 2017-02-21 Lockheed Martin Corporation Graphene-based filter for isolating a substance from blood
WO2015116857A2 (en) 2014-01-31 2015-08-06 Lockheed Martin Corporation Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
JP2017510461A (ja) 2014-01-31 2017-04-13 ロッキード マーティン コーポレイションＬｏｃｋｈｅｅｄ Ｍａｒｔｉｎ Ｃｏｒｐｏｒａｔｉｏｎ 広幅イオン場を用いる二次元材料の穿孔
CA2942496A1 (en) 2014-03-12 2015-09-17 Lockheed Martin Corporation Separation membranes formed from perforated graphene
WO2016036888A1 (en) 2014-09-02 2016-03-10 Lockheed Martin Corporation Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same
WO2017180141A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Selective interfacial mitigation of graphene defects
EP3443329A4 (de) 2016-04-14 2020-04-08 Lockheed Martin Corporation Verfahren zur in-situ-überwachung und -steuerung der defektbildung oder heilung
JP2019511451A (ja) 2016-04-14 2019-04-25 ロッキード・マーチン・コーポレーション 浮遊法を用いてグラフェンシートを大判転写用に処理する方法
KR102260329B1 (ko) 2019-08-05 2021-06-02 주식회사 엘지생활건강 발수 및 발유 특성이 동시에 우수한 고분자 피막제 및 이를 포함하는 화장 지속성이 우수한 화장료 조성물
EP4143135A4 (de) 2020-04-29 2024-06-05 Kao Corporation Selbstbräunende zusammensetzungen enthaltend ein alkylsulfonat und verfahren dafür
CN115461331B (zh) 2020-04-29 2025-08-12 花王株式会社 含有芳香族磺酸盐的自助美黑组合物及其方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2553146A (en) 1946-09-13 1951-05-15 Sulphite Products Corp Production of vanillic acid
US4230817A (en) * 1979-03-02 1980-10-28 Celanese Corporation Thermotropic polyesters derived from ferulic acid and a process for preparing the polyesters
US4690825A (en) 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
US5145675A (en) 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US4714609A (en) * 1986-07-21 1987-12-22 Laverne Stanley Skin tanning composition
US5013497A (en) 1988-03-03 1991-05-07 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
US5218079A (en) 1990-05-18 1993-06-08 Yale University Soluble melanin
US5225435A (en) 1990-05-18 1993-07-06 Yale University Soluble melanin
US5216116A (en) 1990-05-18 1993-06-01 Yale University Soluble melanin
US5227459A (en) 1990-05-18 1993-07-13 Yale University Synthetic melanin
US5260055A (en) * 1991-02-19 1993-11-09 John Imperante Fatty carboxylic silicone amine salts
US5260065A (en) 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
US5247055A (en) 1992-03-20 1993-09-21 Stenger Smith John D Accordion-like polymers for nonlinear applications
US5744125A (en) * 1993-08-19 1998-04-28 Yale University Cosmetic melanins
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents

Also Published As

Publication number Publication date
EP1701689A1 (de) 2006-09-20
US20050129633A1 (en) 2005-06-16
WO2005058262A1 (en) 2005-06-30
CA2547762C (en) 2012-06-19
DE602004025507D1 (de) 2010-03-25
EP1701689B1 (de) 2010-02-10
CA2547762A1 (en) 2005-06-30
US7935331B2 (en) 2011-05-03

Similar Documents

Publication Publication Date Title
DE602004025507D1 (de) Vanillin-polymere zwecks verwendung zur verdunklung der haut
EP1648914A4 (de) Oligomere verbindungen und zusammensetzungen zur verwendung bei der modulierung von kleinen nicht-kodienderen rnas
ATE477249T1 (de) Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes
DE50306850D1 (de) Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen
DE60235866D1 (de) Verwendung von speziellen Aminosilikonen zur Nachbehandlung in der direkten oder oxidativen Färbung von Keratinfasern
DE502006000218D1 (de) Verfahren zur Herstellung von SiOC-verknüpften, linearen Polydialkylsiloxan-Polyoxyalkylen-Blockcopolymeren
ATE381334T1 (de) 2,5-substituiertetetrahydroisochinoline zur verwendung als 5-ht6 modulatoren
DE602004015386D1 (de) Klebestruktur zur Befestigung auf der Haut
ATE433978T1 (de) 5,7-diaminopyrazolo 4,3-d pyrimidine zur verwendung in der behandlung von bluthochdruck
ATE439863T1 (de) Ophthalmische zusammensetzungen von parasympathischen stimulantia und entzündungshemmer zur verwendung bei der behandlung von presbyopie
ATE451402T1 (de) Methacrylatharze zur herstellung von fahrbahnmarkierungen
DE602005027546D1 (de) Aryl- und heteroarylpiperidincarboxylatderivate, deren herstellung und deren verwendung in form von faah-enzyminhibitoren
DE60318744D1 (de) ZUSAMMENSETZUNG AUF BASIS VON 2-CYANOACRYLAT, VERFAHREN UND MITTEL ZUR EVALUIERUNG DER HuRTUNG DAVON
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
DE602004032465D1 (de) Referenzstandard zur charakterisierung von rosuvastatin
DE60329469D1 (de) Herzschrittmacher mit anpassbaren zeitfenstern zur detektion von arrhythmie
ATE319668T1 (de) Verfahren zur synthese von (2s)-indolin-2- carbonsäure, und verwendung in der synthese von perindopril
DE602006010400D1 (de) Olanzapin-analoga und verfahren zu ihrer verwendung
DE602005007220D1 (de) Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
DE602004011674D1 (de) Promotormoleküle zur verwendung in pflanzen
ATE446299T1 (de) Verfahren zur herstellung von 7-ethyl-10- hydroxycamptothecin
NO20053903D0 (no) Nukleotidlipidesterderivater.
ATE507222T1 (de) 1,1-dioxo-thiomorpholinyl-indolyl-methanon- derivate zur verwendung als h3-modulatoren
DE602004030438D1 (de) Neuartiger, zur spaltung der urethanbindung fähiger bacterie
DE50302933D1 (de) Beschichtungsmaterial, Verwendung desselben sowie Verfahren zur Aufbringung des Beschichtungsmaterials

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties